SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?


To: adam hefian who wrote (664)2/13/1998 2:59:00 PM
From: David Cathcart  Respond to of 1826
 
Adam,

It appears that owning this stock brings you misery. While I think that you will profit nicely if you hold a while longer, being miserable is just not worth it. Life's too short, find something to enjoy.

Speaking from another angle though, I do value someone articulating the downside risks of this investment. I miss the posts of Rick Harmon and Miljenko for that reason. If you would like to do that also, please be a little more specific. Tell me why I'm crazy to think MGI-114 will be the best cancer treatment developed to date, or if I'm crazy to think the presence of Salagen will protect me if I'm wrong.

David



To: adam hefian who wrote (664)2/13/1998 3:15:00 PM
From: astro  Respond to of 1826
 
Don't under estimate the power of the mushroom!

A four year base between 4 and 6 only foreshadows the duration and ultimate performance of MOGN. Take advantage of this opportunity.

~"the best stocks I bought did nothing for five years." Peter Lynch

astro